The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at ser579

EMBO Journal

Volumn 18, Issue 4, 1999, Pages 893-903

  Hoffmann, Ralf ^a,b   Baillie, George S ^a   MacKenzie, Simon J ^a   Yarwood, Stephen J ^a   Houslay, Miles D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Biofrontera Pharmaceuticals GmbH   (Germany)

Author keywords

Cyclic AMP phosphodiesterase; ERK2; MAP kinase; Phosphorylation; Protein kinase A

Indexed keywords

CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COS CELLS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTATION; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSFECTION;

ANIMALIA;

EID: 0033558010     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.4.893     Document Type: Article

References (60)

1. Alvarez, E., Northwood, I.C., Gonzalez, F.A., Latour, D.A., Seth, A., Abate, C., Curran, T. and Davis, R.J. (1991) Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem., 266, 15277-15285.
2. Alvarez, R., Sette, C., Yang, D., Eglen, R.M., Wilhelm, R., Shelton, E.R. and Conti, M. (1995) Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol. Pharmacol., 48, 616-622.
3. Barnette, M.S., Christensen, S.B., Essayan, D.M., Grous, M., Prabhakar, U., Rush, J.A., Kagey-Sobotka, A. and Torphy, T.J. (1998) SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: In vitro anti-inflammatory actions. J. Pharmacol. Exp. Ther., 284, 420-426.
4. Beavo, J.A. (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol. Rev., 75, 725-748.
5. Beavo, J.A., Conti, M. and Heaslip, R.J. (1994) Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46, 399-405.
6. Blumer, K.J. and Johnson, G.L. (1994) Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci., 19, 236-240.
7. Bolger, G. (1994) Molecular Biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell. Signal., 6, 851-859.
8. Bolger, G., Michaeli, T., Martins, T., St John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M. and Ferguson, K. (1993) A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol. Cell. Biol., 13, 6558-6571.
9. Bolger, G.B., Erdogan, S., Jones, R.E., Loughney, K., Scotland, G., Hoffmann, R., Wilkinson, I., Farrell, C. and Houslay, M.D. (1997) Characterisation of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem. J., 328, 539-548.
10. Bolger, G.B., McPhee, I. and Houslay, M.D. (1996) Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8. J. Biol. Chem., 271, 1065-1071.
11. Bradford, M. (1976) Protein determination in biological samples. Anal. Biochem., 72, 248-254.
12. Chen, Z., Nield, H.S., Sun, H., Barbier, A. and Patel, T.B. (1995) Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J. Biol. Chem., 270, 27525-27530.
13. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T. and Hidaka, H. (1990) Inhibition of forskolin-induced neunte outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
14. Conti, M., Nemoz, G., Sette, C. and Vicini, E. (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr. Rev., 16, 370-389.
15. Cook, S.J. and McCormick, F. (1993) Inhibition by cAMP of ras-dependent activation of raf. Science, 262, 1069-1072.
16. Cook, S.J., Rubinfeld, B., Albert, I. and McCormick, F. (1993) RapV12 antagonizes ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts. EMBO J., 12, 3475-3485.
17. Dent, G. and Giembycz, M.A. (1995) Selective phosphodiesterase inhibitors in the therapy of asthma. Clin. Immunother., 3, 423-437.
18. Fanger, G.R., Johnson, N.L. and Johnson, G.L. (1997) MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J., 16, 4961-4972.
19. Faux, M.C. and Scott, J.D. (1996) More on target with protein phosphorylation: conferring specificity by location. Trends Biochem. Sci., 21, 312-318.
20. Gonzalez, F.A., Raden, D.L. and Davis, R.J. (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem., 266, 22159-22163.
21. Heyworth, C.M. and Houslay, M.D. (1983) Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes. Biochem. J., 214, 93-98.
22. Hoffmann, R., Wilkinson, I.R., McCallum, J.F., Engels, P. and Houslay, M.D. (1998) cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model. Biochem. J., 333, 139-149.
23. Hordijk, P.L., Verlaan, I., Jalink, K., Van Corven, E.J. and Moolenaar, W.H. (1994) cAMP abrogates the p21 (ras)-mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem., 269, 3534-3538.
24. Houslay, M.D. (1990) The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocytes intracellular cyclic AMP concentrations. Cell. Signal., 2, 85-98.
25. Houslay, M.D. and Milligan, G. (1997) Tailoring cAMP signalling responses through isoform multiplicity. Trends Biochem. Sci., 22, 217-224.
26. Houslay, M.D., Sullivan, M. and Bolger, G.B. (1997) The multi-enzyme PDE4 cyclic AMP specific phosphodiesterase family: intracellular targeting, regulation and selective inhibition by compounds exerting anti-inflammatory and anti-depressant actions. Adv. Pharmarol., 44, 225-342.
27. Hughes, B., Owens, R., Perry, M., Warrellow, G. and Allen, R. (1997) PDE 4 inhibitors: The use of molecular cloning in the design and development of novel drugs. Drug Discov. Today, 2, 89-101.
28. Kolch, W., Philipp, A., Mischak, H., Dutil, E.M., Mullen, T.M., Feramisco, J.R., Meinkoth, J.L. and Rose, D.W. (1996) Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding. Oncogene, 13, 1305-1314.
29. Kreis, T.E. and Lodish, H.F. (1986) Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell, 46, 929-937.
30. Laemmli, U.K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 227, 680-682.
31. Lange-Carter, C.A., Pleiman, C.M., Gardner, A.M., Blumer, K.J. and Johnson, G.L. (1993) A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science, 260, 315-319.
32. Lenhard, J.M., Kassel, D.B., Rocque, W.J., Hamacher, L., Holmes, W.D., Patel, I., Hoffman, C. and Luther, M. (1996) Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase. Biochem. J., 316, 751-758.
33. Lobban, M., Shakur, Y., Beattie, J. and Houslay, M.D. (1994) Identification of two splice variant forms of type-IV (B) cyclic AMP phosphodiesterase. DPD (rPDE-IV (B1)) and PDE-4 (rPDE-IV (B2)) in brain: Selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem. J., 304, 399-406.
34. MacKenzie, S., Fleming, I., Houslay, M.D., Anderson, N.G. and Kilgour, E. (1997) Growth hormone and phorbol esters require specific protein kinase C isoforms to activate mitogen-activated protein kinases in 3T3-F442A cells. Biochem. J., 324, 159-165.
35. MacKenzie, S.J., Yarwood, S.J., Peden, A.H., Bolger, G.B., Vernon, R.J. and Houslay, M.D. (1998) Stimulation of p70S6 kinase via a growth hormone controlled PI-3 kinase pathway leads to the activation of a PDE4 cAMP specific phosphodiesterases in 3T3-F442A preadipocytes. Proc. Natl Acad. Sci. USA, 95, 3549-3554.
36. Manganiello, V.C., Taira, M., Degerman, E. and Belfrage, P. (1995) Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family). Cell. Signal., 7, 445-455.
37. Marchmont, R.J. and Houslay, M.D. (1980) An intrinsic and a peripheral protein constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem. J., 187, 381-392.
38. McPhee, I., Pooley, L., Lobban, M., Bolger, G. and Houslay, M.D. (1995) Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem. J., 310, 965-974.
39. Mischak, H., Seitz, T., Janosch, P., Eulitz, M., Steen, H., Schellerer, M., Philipp, A. and Kolch, W. (1996) Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol., 16, 5409-5418.
40. Nair, B.G., Parikh, B., Milligan, G. and Patel, T.B. (1990) Gsα mediates epidermal growth factor-elicited stimulation of rat cardiac adenylate cycla. J. Biol. Chem., 265, 21317-21322.
41. Pang, L., Sawada, T., Decker, S.J. and Saltiel, A.R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol Chem., 270, 13585-13588.
42. Poppleton, H., Sun, H., Fulgham, D., Bertics, P. and Patel, T.B. (1996) Activation of Gsα by the epidermal growth factor receptor involves phosphorylation. J. Biol. Chem., 271, 6947-6951.
43. Rubin, C.S. (1994) A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim. Biophys. Acta, 1224, 467-479.
44. Scotland, G. and Houslay, M.D. (1995) Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IV (A1)) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase. Biochem. J., 308, 673-681.
45. Scott, J.D. and McCartney, S. (1994) Localization of A-kinase through anchoring proteins. Mol. Endocrinol., 8, 5-11.
46. Sette, C. and Conti, M. (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem., 271, 16526-16534.
47. Sette, C., Iona, S. and Conti, M. (1994) The short-term activation of a Rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J. Biol. Chem., 269, 9245-9252.
48. Shakur, Y., Pryde, J.G. and Houslay, M.D. (1993) Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J., 292, 677-686.
49. Shakur, Y., Wilson, M., Pooley, L. Lobban, M., Griffiths, S.L., Campbell, A.M., Beattie, J., Daly, C. and Houslay, M.D. (1995) Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem. J., 306, 801-809.
50. Soldati, T. and Perriard, J.C. (1991) Intracompartmental sorting of essential myosin light chains: Molecular dissection and in vivo monitoring by epitope tagging. Cell, 66, 277-289.
51. Souness, J.E. and Rao, S. (1997) Proposal for pharmacologically distinct conformers of PDE4. Cell. Signal., 9, 227-236.
52. Sun, H., Chen, Z., Poppleton, H., Scholich, K., Mullenix, J., Weipz, G.J., Fulgham, D.L., Bertics, P.J. and Patel, T.B. (1997) The juxtamembrane, cytosolic region of the epidermal growth factor receptor is involved in association with α-subunit of Gs. J. Biol. Chem., 272, 5413-5420.
53. Swinnen, J.V., Joseph, D.R. and Conti, M. (1989) Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: Evidence for a family of genes. Proc. Natl Acad. Sci. USA, 86, 5325-5329.
54. Tang, E.K.Y. and Houslay, M.D. (1992) Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity. Biochem. J., 283, 341-346.
55. Thompson, W.J. (1991) Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol. Ther, 51, 13-33.
56. Thompson, W.J. and Appleman, M.M. (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry, 10, 311-316.
57. Torphy, T.J. (1998) Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Resp. Crit. Care Med., 157, 351-370.
58. Torphy, T.J., Undem, B.J., Cieslinski, L.B., Luttmann, M.A., Reeves, M.L. and Hay, D.W.P. (1993) Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J. Pharmacol. Exp. Ther., 265, 1213-1223.
59. Wilkinson, I., Engels, P. and Houslay, M.D. (1997) Rolipram inhibition of the human cyclic AMP phosphodiesterase splice varinat HSPDE4D3 expressed in yeast (S.cerevisiae). Pharmacol. Rev. Commun., 9, 215-226.
60. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M.J. and Sturgill, T.W. (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science, 262, 1065-1069.